Skip to content 
Vitro Biopharma, Inc. is a biotechnology company targeting autoimmune diseases and inflammatory disorders, with an ancillary focus in the research services and cosmeceutical fields. The Company is focused on developing therapeutic products, its stem cell technology, patent portfolio and proprietary technology and cell lines for applications in autoimmune disorders and inflammatory disease processes and stem cell research. The Company is engaged in the development of cellular therapeutic candidates intended to address significant unmet medical needs. In the United States, the Company is authorized to conduct two clinical trials under two Food and Drug Administration (FDA) Investigational New Drug applications to assess the safety and efficacy of AlloRx Stem Cell therapy in PTHS and Long COVID. It is also engaged in various other activities, including providing research services and stem cell products, as well as cosmeceuticals, through its wholly owned subsidiary, namely InfiniVive MD. more
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| VTRO | |
|---|---|
| ROA (LTM) | 0.00% |
| ROE (LTM) | 0.00% |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| VTRO | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 0.00 |
| P/B | 0.00 |
| EV/R | 0.00 |
| EV/Ebitda | NM |
Vitro Biopharma (VTRO) share price today is $0
Yes, Indians can buy shares of Vitro Biopharma (VTRO) on Vested. To buy
Yes, you can purchase fractional shares of Vitro Biopharma (VTRO) via the Vested app. You can start investing in Vitro Biopharma (VTRO) with a minimum investment of $1.
You can invest in shares of Vitro Biopharma (VTRO) via Vested in three simple steps:
The 52-week high price of Vitro Biopharma (VTRO) is $. The 52-week low price of Vitro Biopharma (VTRO) is $.
The price-to-earnings (P/E) ratio of Vitro Biopharma (VTRO) is
The price-to-book (P/B) ratio of Vitro Biopharma (VTRO) is 0.00
The dividend yield of Vitro Biopharma (VTRO) is 0.00%
The market capitalization of Vitro Biopharma (VTRO) is
The stock symbol (or ticker) of Vitro Biopharma is VTRO
Consider the share price of Vitro Biopharma as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Vitro Biopharma has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Vitro Biopharma shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Vitro Biopharma stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Vitro Biopharma and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Vitro Biopharma stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
